Mark Parry-Billings, chief development officer, and Lisa Nolan, senior vice president, Business Development, remain in their leadership roles and will work closely with company’s board of directors to continue to advance development efforts of the company’s portfolio of respiratory products. The board has initiated a search for a new CEO to lead the company through late-stage clinical development.
Barbara Van Oye, company’s director of finance, will continue to manage the company’s financial operations.